Tuberculoma

From IDWiki
Revision as of 19:40, 13 June 2023 by Aidan (talk | contribs) ()
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

Pathophysiology

  • Collection of granulomatous tissue that results from hematogenous spread of Mycobacterium tuberculosis
  • They are a granulomatous lesion of epithelioid cells and Langerhans giant cells surrounded by lymphocytes
  • Progress from non-caseating to solid with central caseation to central liquifaction
    • The last stage is indistinguishable from other brain abscesses but has low bacillary burden
  • In the CNS, may rupture and cause tuberculous meningitis

Epidemiology

  • Cerebral tuberculomas are more common in patients with HIV

Clinical Manifestations

Cerebral Tuberculoma

  • Often asymptomatic
  • Most commonly presents in conjunction with tuberculous meningitis, though can present alone
  • In CNS, may present with headache, seizures, or focal neurological deficits
  • There are numerous case reports of intracranial tuberculomas developing while on therapy1

Pulmonary Tuberculoma

  • Typically asymptomatic, developing at the site of initial disease
  • Usually static, but can cavitate and spread new disease

Other Sites

  • Also case reports of tuberculomas in liver, heart, peripheral nerve, spine

Differential Diagnosis

Diagnosis

  • Based on imaging, with ring-enhancing lesion with surrounding edema
  • If there is uncertainty about the diagnosis, may need biopsy

Management

  • Manage per primary diagnosis, with at least 6 months of standard therapy
  • Dexamethasone can be considered for CNS tuberculoma with surrounding vasogenic edema and neurologic symptoms

References

  1. ^  Deborah J Nicolls, Mark King, David Holland, Jennifer Bala, Carlos del Rio. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. The Lancet Infectious Diseases. 2005;5(12):795-801. doi:10.1016/s1473-3099(05)70299-1.